glp-1 kidney outcomes news Updated evidence on cardiovascular and renal effects of receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology Renal outcomes of SGLT2 inhibitors

8 Compared with placebo, once weekly tirzepatide significantly reduced the combined risk of cardiovascular death or worsening HF events (hospitalisation or an urgent hospital visit requiring intravenous therapy)

L.AliakbariS.ZavoshA.SipolsA

L-carnitine accomplishes this by binding to acyl residues produced not only from fatty acids but also from amino acid metabolism, forming water-soluble acylcarnitines that facilitate their excretion from cells and ultimately the body (Figure 1) (19, 20)

Visibly clear signs of zombie cell damage* with a breakthrough 6.1% Tri-Senolytic System featuring 3% Eterwell Youth

Lebon, T